# Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/product-name-placement-size-and-prominence-in-advertising-and-promotional-labeling-final/fa68136f-ad70-49ea-a8cd-cc47e646f4a1

> FDA guidance document: Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final. Issue date: December 12, 2017. Get complete insights and analysis.

---

## Details

- Title: Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling-Final
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-12-12
- Last Changed: 2021-09-30
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1999-D-4079">FDA-1999-D-4079</a>

## Related Documents

- [Presenting Quantitative Efficacy and Risk Information in  Direct-to-Consumer (DTC) Promotional Labeling and Advertisements](https://www.globalkeysolutions.net/guidances/guidance-document/presenting-quantitative-efficacy-and-risk-information-in-direct-to-consumer-dtc-promotional-labeling-and-advertisements/bb6d5d7c-0aa7-47cd-9c04-8a080c2201b7)
- [Nonproprietary Naming of Biological Products Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonproprietary-naming-of-biological-products-guidance-for-industry/2c820442-8476-4109-a13c-a42550929546)
- [Individual Patient Expanded Access Applications: Form FDA 3926](https://www.globalkeysolutions.net/guidances/guidance-document/individual-patient-expanded-access-applications-form-fda-3926/6de5fa70-12b9-446e-a760-cc6dd4a4cb1d)